A novel screening biomarker in gastric cancer: Serum Dickkopf-1

Hepato-Gastroenterology

Volumn 59, Issue 117, 2012, Pages 1661-1664

  Gomceli, Ismail ^a   Bostanci, Erdal B ^a   Ozer, Ilter ^a   Kemik, Ahu S ^b   Turhan, Nesrin ^a   Tez, Mesut ^c   Kilic, Selim ^d   Demiriz, Baris ^c   Akoglu, Musa ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adenocarcinoma; Dickkopf 1 protein; Gastric cancer

Indexed keywords

BIOLOGICAL MARKER; DICKKOPF 1 PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; TURKEY (REPUBLIC);

ADENOCARCINOMA; AREA UNDER CURVE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TURKEY;

EID: 84865199102     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11516     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Crew KD, Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 2006; 12:354-362.
3. Brenner H, Rothenbacher D, Arndt V: Epidemiology of stomach cancer. Method Biol 2009; 472:467-477.
4. Fiocca R, Luinetti O, Villanl L, et al.: Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepato-gastroenterol 2001; 48:1523-1530.
5. El-Rifai W, Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 2002; 12:128-140.
6. Willert K, Jones KA: Wnt signaling: is the party in the nucleus? Genes Dev 2006; 20:1394-1404.
7. Jass JR, Barker M, Fraser L, et al.: APC mutation and tumor budding in colorectal cancer. J Clin Pathol 2003; 56:69-73.
8. Mikesch JH, Steffen B, Berdel WE, et al.: The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 2007; 21:1638-1647.
9. Turashvili G, Bouchai J, Burkadze G, Kolar Z: Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2006; 73:213-223.
10. Yardy GW, Brewster SF: Wnt signaling and prostate cancer. [Prostate Cancer Prostatic Dis 2005; 8:119-126.
11. Thompson MD, Monga SP: WNT/catenin signaling in liver health and disease. Hepatology 2007; 45:1298-1305.
12. Yamabuki T, Takano A, Hayama S, et al.: Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 2007; 67(6):2517-2525.
13. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y: Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 2006; 12:4873-4874.
14. Leung WK, Wu MS, Kakugawa Y, et al.: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9:279-287.
15. Kwak MS, Kim N, Lee HS, Lee HE, Jung HC, Song IS: Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histological risk index. Dig Dis Sci 2010; 55:2275-2282.
16. Kim N, Jung HC: The role of serum pepsinogen in the detection of gastric cancer. Gut Liver 2010; 4:307-319.
17. Miki K: Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006; 9:245-253.
18. Oue N, Sentani K, Noguchi T, et al.: Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009; 125:2383-2392.
19. Kobayashi Y, Niwa Y, Tajika M, et al.: Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. Hepato-Gastroenterol 2010; 57:1631-1634.
20. Curtin JC, Lorenzi MV: Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010; 1:563-577.
21. Gonzalez-Sancho JM, Aguilera O, Garcia JM, et al.: The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is down regulated in human colon cancer. Oncogene 2005; 24(6):1098-1103.
22. Suzuki R, Onizuka M, Kojima M, et al.: Preferential hyper methylation of the Dickkopf-1 promoter in core-binding factor leukemia. Br J Haematol 2007; 138(5):624-631.
23. Tian E, Zhan F, Walker R, et al.: The role of the Wnt-signaling antagonist DKK-1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003; 349:2483-2494.
24. Wirths O, Waha A, Weggen S, et al.: Over expression of human Dickkopf-1, an antagonist of wingless/WNT signaling in human hepatoblastomas and Wilms' tumors. Lab Invest 2003; 83:429-434.
25. Wodarz, A, Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Bi 1998; 14:59-88.